维普中文期刊产品整合服务

Effect of Weight Loss on Survival in Esophageal Cancer Patients undergoing Neoadjuvant Chemoradiotherapy and Surgery

查看全文 作　　者：Jia Hua [1,2]Lyu;Tao [1,2]Li;Yong Tao [1,3]Han;Lei [2]Wu;Lin [3]Peng;Qi Feng [2]Wang;Long [2]Liang 高影响力作者 机构地区：[1]Department of the Chest Radiation Oncology,School of Medicine,University of Electronic Science and Technology of China,Sichuan,Chengdu,Sichuan 610041,China;[2]Department of Radiotherapy,Sichuan Cancer Hospital&Institute,School of Clinical Medicine,University of Electronic Science and Technology of China,Chengdu 610041,Sichuan,China;[3]Department of Thoracic Surgery,Sichuan Cancer Hospital&Institute,Chengdu,Sichuan 610041,Sichuan,China高影响力机构 出　　处：《Journal of Nutritional Oncology》索引2020年第5卷第3期,共10页高影响力期刊 基　　金：the Sichuan Province Health Research Project(No.19PJ276)。 摘　　要：Objective This study aimed to determine the impact of weight loss during neoadjuvant chemoradiotherapy on the survival of patients with esophageal carcinoma.Methods We retrospectively examined 102 consecutive patients with esophageal carcinoma who underwent neoadjuvant chemoradiotherapy followed by radical resection at Sichuan Cancer Hospital&Institute between 2003 and 2017.The patients were divided into three groups based on the amount of body weight lost during neoadjuvant chemoradiotherapy:severe weight loss(>10%),high weight loss(5%~10%),and low weight loss(<5%).The correlations of weight loss with toxicity,progressionfree survival,and overall survival were investigated.Results The median overall survival was 49.7 months in the low weight loss group compared with 35.4 and 25.1 months in the high and severe weight loss groups(P=0.041).The 1-year overall survival rates in the severe,high,and low weight loss groups were 62.5%,85.0%,and 90.7%,respectively;the corresponding 3-year overall survival rates were 21.9%,47.3%,and 68.8%,respectively,and the corresponding 5-year overall survival rates were 21.9%,31.0%,and 44.4%,respectively.The multivariate analysis indicated that a pathological complete response and severe weight loss were independent prognostic factors for overall survival.Any leukopenia(P=0.024),leukopenia of at least grade 3(P=0.021),and anemia(P=0.042)occurred more frequently in the severe weight loss group.Conclusions Weight loss during neoadjuvant CRT is an independent and adverse prognostic factor in esophageal carcinoma patients,whereas a stable weight confers a better prognosis. 关 键 词：Esophageal cancer PROGNOSIS Weight loss Neoadjuvant chemoradiotherapy TOXICITY
相关文献

参考文献(40)

引证文献(7)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费